This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignees: Nrl Pharma, Inc., Saraya Co., Ltd.. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2019
Title: Takashi Takeuchi: Innovator in Pharmaceutical Compositions
Introduction
Takashi Takeuchi is a notable inventor based in Tottori, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at improving patient care. With a total of 2 patents, his work focuses on enhancing the bioavailability of active substances and providing relief from pain and anxiety.
Latest Patents
One of his latest patents is a composition comprising sophorolipid, a physiologically active substance, and oil or fat. This invention aims to create an orally administered composition that improves the bioavailability of the physiologically active substance. Another significant patent involves a novel pharmaceutical composition designed to alleviate pain and anxiety in patients. This composition contains lactoferrin as an active ingredient and is particularly beneficial for patients suffering from end-stage cancer, as well as those experiencing various forms of arthritis.
Career Highlights
Throughout his career, Takashi Takeuchi has worked with reputable companies such as NRL Pharma, Inc. and Saraya Co., Ltd. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Takashi has collaborated with notable individuals in his field, including Etsumori Harada and Kenichiro Hayashida. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Takashi Takeuchi's contributions to pharmaceutical compositions demonstrate his commitment to improving patient outcomes. His innovative work continues to impact the field positively, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
